Daratumumab for disabling cold agglutinin disease refractory to B-cell directed therapy

Am J Hematol. 2020 Oct;95(10):E293-E295. doi: 10.1002/ajh.25932. Epub 2020 Aug 7.

Authors

Oliver Tomkins¹, Sigbjørn Berentsen², Suzanne Arulogun¹, Mallika Sekhar¹, Shirley D'Sa¹

Affiliations

¹ Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
² Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway.

PMID: 32652632
DOI: 10.1002/ajh.25932

No abstract available

Publication types

Letter